The need for a point of care testing: An evidence-based appraisal

References

• AIMS (Anistreplase Intervention Mortality study) Trial study group. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo controlled clinical trial. Lancet 1988; i: 545–549
   Google Scholar
• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet Aug 13, 1988; 2(8607)349–60
   PubMed Web of Science ®Google Scholar
• Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico. GISSI. Lancet 1987; ii: 871–4
   Google Scholar
• Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet. 1993; 342: 759–66
   PubMed Web of Science ®Google Scholar
• Wilcox R G, von der Lippe G., Olsson C. G., Jensen G., Skene A M, Hampton J R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; ii: 525–30
   Google Scholar
• Wilcox R G, von der Lippe G. C., Olsson G., Jensen G., Skene A. M., Hampton J R. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis. Lancet. 1990; 335: 1175–8
   PubMed Web of Science ®Google Scholar
• Fibrinolytic Therapy Trialists Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311–22
   PubMed Web of Science ®Google Scholar
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994; 89: 1545–56
   PubMed Web of Science ®Google Scholar
• Lee T H, Weisberg M C, Brand D A, Rouan G W, Goldman L. Candidates for thrombolysis among emergency room patients with acute chest pain. Ann. Internal. Medicine. 1989; 110: 957–962
   Web of Science ®Google Scholar
• Adams J N, Jamieson M, Trent R J, Rawles J, Jennings K P. The risks of thrombolysis in patients without acute myocardial infarction. International Journal of Cardiology 1995; 51: 177–81
   PubMed Web of Science ®Google Scholar
• Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94: 1291–7
   PubMed Web of Science ®Google Scholar
• Ohman M E, Armstrong P W, Christenson R H, Granger C B, Katus H A, Hamm C W, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischaemia. NEJM 1996; 335: 1333–41
   PubMed Web of Science ®Google Scholar
• Antman E M, Tanasijeevic M J, Thompson B, Schactman M, McCabe C H, Cannon C P, et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. NEJM 1996; 335: 1342–9
   PubMed Web of Science ®Google Scholar
• McQueen M, Holder D., El-Maraghi N. Assessment of the accuracy of serial electrocardiography in the diagnosis of acute myocardial infarction. Am Heart J. 1983; 105: 258–61
   PubMed Web of Science ®Google Scholar
• Zarling E J, Sexton H, Milnor P. Failure to diagnose acute myocardial infarction. JAMA 1983; 250: 1177–81
   PubMed Web of Science ®Google Scholar
• Slater D K, Hlatky M A, Mark D B, Harrel F E, Pryor D B, Califf R M. Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings. Am. J. Cardiol. 1987; 60: 766–770
   Web of Science ®Google Scholar
• Brush J E, Brand D A, Acampora A, Chalmer B, Wackers F J. Use of the admission electrocardiogram to predict in-hospital complications of acute myocardial infarction. NEJM 1985; 312: 1137–1141
   PubMed Web of Science ®Google Scholar
• Yusuf S, Pearson M, Sterry H, Parish S, Ramsdale D, Rossi P, Sleight P. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction. European Heart Journal. 1984; 5: 690–646
   PubMed Web of Science ®Google Scholar
• Collinson P O, Ramhamadamy E M, Rosalki S B, Joffe J, Evans D H, Fink R S, Greenwood T W, Baird I M. Diagnosis of acute myocardial infarction from sequential enzyme measurements obtained within 12 hours of admission to hospital. J. Clin. Pathol. 1989; 42: 1126–31
   Web of Science ®Google Scholar
• Collinson P O, Stubbs P J. 4 hour “rule-in” diagnosis of acute myocardial infarction for early risk stratification by creatine kinase increment (CK change). Ann Clin Biochem 1996; 33: 308–13
   PubMed Web of Science ®Google Scholar
• Mair J, Smidt J, Lechleitner P, Dienstl F, Puschendorf B. Rapid accurate diagnosis of acute myocardial infarction in patients with nontraumatic chest pain within 1 h of admission. Coronary Artery Disease. 1995; 6: 539–45
   PubMed Web of Science ®Google Scholar
• Lindahl B, Venge P, Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemical Markers of Acute Coronary Syndromes. Coronary Artery Disease. 1995; 6: 321–8
   PubMed Web of Science ®Google Scholar
• Young G P, Gibler W B, Hedges J R, Hoekstra J W, Slovis C, Aghababian R, Smith M, Rubison M, Ellis J. Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with non diagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study. Academic Emergency Medicine. 1997; 4: 869–77
   PubMed Web of Science ®Google Scholar
• Hamm C W, Goldmann B U, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. New England Journal of Medicine. 1997; 337: 1648–53
   PubMed Web of Science ®Google Scholar
• Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996; 313: 262–4
   PubMed Web of Science ®Google Scholar
• Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–7
   PubMed Web of Science ®Google Scholar
• Collinson P O. T or I or MB (or none?). European Heart Journal 1998; 19: N16–24, (Suppl N)
   PubMed Web of Science ®Google Scholar
• Lindahl B., Venge P., Wallentin L. T Troponin identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. Journal of the American College of Cardiology, 29: 43–8
   PubMed Web of Science ®Google Scholar
• White H, Stewart J T, French J K, Theroux P, Ramanathan K, Solymoss B C, Johnson R, White H D. Early non-invasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. Journal of the American College of Cardiology. 1998; 31: 1499–505
   PubMed Web of Science ®Google Scholar
• Hamm C W, Heeschen C, Goldman B U, et al. Value of troponins in predicting therapeutic efficacy of abciximab in patients with unstable angina. JACC 1998; 31: 185A, (suppl A)
   Google Scholar
• Collinson P O, Ramhamadamy E M, Stubbs P J, Rosalki S B, Garrat H M, Mosely D, Evans D H, Fink F S, Baird I M, Greenwood T W. Rapid enzyme diagnosis of patients with acute chest pain reduces patient stay in the coronary care unit. Ann Clin Biochem. 1993; 30: 17–22
   PubMed Web of Science ®Google Scholar
• Gibler W B, Runyon J P, Levy R C, Sayre M R, Kacich R, Hattemer C R, Hamilton C, Gerlach J W, Walsh R A. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Annals of Emergency Medicine. 1995; 25: 1–8, 1995 Jan.
   PubMed Web of Science ®Google Scholar
• Hedges J R, Gibler W B, Young G P, Hoekstra J W, Slovis C, Aghababian R, Smith M, Rubison M. Multicenter study of creatine kinase-MB use: effect on chest pain clinical decision making. Academic Emergency Medicine. 1996; 3: 7–15
   PubMed Web of Science ®Google Scholar
• Wu A H, Clive J M. Impact of CK-MB testing policies on hospital length of stay and laboratory costs for patients with myocardial infarction or chest pain. Clinical Chemistry. 1997; 43: 326–32
   PubMed Web of Science ®Google Scholar
• Apple F S, Preese L M, Riley L, Gerken K L, Van Lente F. Financial impact of a rapid CK-MB-specific immunoassay on the diagnosis of myocardial infarction. Archives of Pathology & Laboratory Medicine. 1990; 114: 1017–20
   PubMed Web of Science ®Google Scholar
• Ramhamadamy E, Collinson P O, Evans D H, Fink R S, Baird I M. Evaluation of the AMES seralyser for measurement of creatine kinase in the coronary care unit. Clin Chem 1988; 34: 1914
   Google Scholar
• Schouten Y, de Winter R J, Gorgels J P, Koster R W, Adams R, Sanders G T. Clinical evaluation of the cardiac STATus, a rapid immunochromatographic assay for simultaneous detection of elevated concentrations of CK-MB and myoglobin in whole blood. Clinical Chemistry & Laboratory Medicine. 1998; 36: 469–73
   PubMed Web of Science ®Google Scholar
• Brogan G X, Jr., Bock J L, McCuskey C F, Hollander J E, Thode H, Jr., Gawad Y, Jackowski G. Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction. Clinics in Laboratory Medicine. 1997; 17: 655–68
   PubMed Web of Science ®Google Scholar
• Collinson P O, Thomas S, Siu L, Vasudeva P, Stubbs P J, Canepa-Anson R. Rapid troponin T measurement in whole blood for detection of myocardial damage. Annals of Clinical Biochemistry. 1995; 32: 454–8, 1995
   PubMed Web of Science ®Google Scholar
• Collinson P O, Gerhardt W, Katus H A, Muller-Bardorff M, Braun S, Schricke U, Vogt W, Nagel D, Zander M, Leinberger R, Mangold D, Zerback R. Multicentre evaluation of an immunological rapid test for the detection of troponin T in whole blood samples. European Journal of Clinical Chemistry & Clinical Biochemistry. 1996; 34: 591–8
   PubMedGoogle Scholar
• Muller-Bardorff M, Freitag H, Scheffold T, Remppis, Kubler W, Kattus H A. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 1995; 92: 2869–75
   PubMed Web of Science ®Google Scholar
• Hirschl M M, Lechleitner P, Friedrich G, Sint G, Sterz F, Binder M, Dienstl F, Laggner A N. Usefulness of a new rapid bedside troponin T assay in patients with chest pain. Resuscitation. 1996; 32: 193–8
   PubMed Web of Science ®Google Scholar
• Gerhardt W, Ljungdahl L, Collinson P O, Lovis C, Mach F, Sylven C, Rasmanis G, Leinberger R, Zerback R, Muller-Bardorff M, Katus H A. An improved rapid troponin T test with a decreased detection limit: a multicentre study of the analytical and clinical performance in suspected myocardial damage. Scandinavian Journal of Clinical & Laboratory Investigation. 1997; 57: 549–57
   PubMed Web of Science ®Google Scholar
• Muller-Bardorff, Waldenhofer U, Sylven C, Collinson P O, Gerhardt W, Hafner G, Zerback R M, Katus H A. Multicentre evaluation of a new point of care system for the quantiative determination of troponin T and myoglobin. Clin Chem 1998; 44: A129, Suppl
   Google Scholar
• Anonymous. Evaluation of a bedside whole-blood rapid troponin T assay in the emergency department. Rapid Evaluation by Assay of Cardiac Troponin T (REACTT) Investigators Study Group. Academic Emergency Medicine. 1997; 4: 1018–24, 1997
   PubMed Web of Science ®Google Scholar
• Heeschen C, Goldmann B U, Moeller R H, Hamm C W. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clinical Chemistry. 1998; 44: 1925–30
   PubMed Web of Science ®Google Scholar
• Panteghini M., Cuccia C., Pagani F., Turla C. Comparison of the diagnostic performance of two rapid bedside biochemical assays in the early detection of acute myocardial infarction. Clinical Cardiology. 1998; 21: 394–8
   PubMed Web of Science ®Google Scholar
• Sylven C, Lindahl S, Hellkvist K, Nyquist O, Rasmanis G. Excellent reliability of nurse-based bedside diagnosis of acute myocardial infarction by rapid dry-strip creatine kinase MB, myoglobin, and troponin T. American Heart Journal. 1998; 135: 677–83
   PubMed Web of Science ®Google Scholar
• Luscher M S, Ravkilde J, Thygesen K. Clinical application of two novel rapid bedside tests for the detection of cardiac troponin T and creatine kinase-MB mass/myoglobin in whole blood in acute myocardial infarction. Cardiology. 1998; 89: 222–8
   PubMed Web of Science ®Google Scholar
• Hamm C W, Goldmann B U, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. New England Journal of Medicine. 1997; 337: 1648–53
   PubMed Web of Science ®Google Scholar
• Hoekstra J W, Gibler W B, Levy R C, Sayre M, Naber W, Chandra A, et al. Emergency department diagnosis of acute myocardial infarction and ischaemia: A cost analysis of two diagnostic protocols. Acad Emerg Med 1994; 1: 103–10
   PubMedGoogle Scholar
• Gomez M A, Andesron J L, Karagounis L A, Muhlestein J B, Mooers F B. An emergency department based protocol for rapidly ruling out myocardial ischaemia reduces hospital time and expense: results of a randomised study (RO-MIO). Journal of the American College of Cardiology; 1996; 28: 25–33
   PubMed Web of Science ®Google Scholar
• Collinson P O. Cost economics of new cardiac markers - CK-MB and cardiac troponins. Myocardial damage: Early detection by novel biochemical markers, C J Kaski, D Holt. Kluwer Academic Publishers B.V., The Netherlands 1998
   Google Scholar